International Patent: TARGETED COMBINATION THERAPY FOR PREVENTING ADVERSE PREGNANCY OUTCOMES

GENEVA, Sept. 7 -- THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY filed a patent application (US2026/017168) for “TARGETED COMBINATION THERAPY FOR PREVENTING ADVERSE PREGNANCY OUTCOMES”. With publication no. WO/2026/183531, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/4439

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....